Intergrin has raised financing provided by Kartesia
Intergrin has obtained a unitranche loan of approximately US$59 million to refinance existing debt and to further support the growth of different healthcare and well-being initiatives.
Intergrin is a Dutch healthcare provider that operates clinics focused on specialized mental healthcare through its two brands, Het Rughuis and PHI. The company is headquartered in Geleen and currently has twelve treatment locations across the south of the country. Het Rughuis provides psychosomatic treatments to individuals with spine-related pain disorders through a combination of expert cognitive behavioral therapy, lifestyle-as-a-medicine therapy, vitality and physical therapy. PHI offers specialized psychosomatic mental healthcare to those suffering from anxiety, depression, somatoform disorder and serious unexplained physical complaints. Intergrin has unrivalled high success rates and delivers sustainable results, thereby significantly improving the quality of life of patients while also lowering the medical costs to society.
The loan was provided by Kartesia, a pan-European, independent and privately owned specialist provider of financing solutions, focused on offering customized resources across the capital structure to leading mid-market companies from a wide range of industries, with the view to accelerate their pace of growth.
Oaklins’ debt advisory team in the Netherlands advised Intergrin in this transaction and assisted in establishing a financing package aligned with the current business profile and future growth ambitions. This transaction emphasizes Oaklins’ strong track record in the healthcare clinics sector, which previously included deals such as Tandarts Today, Curious Kids and Dutch Dental Group.
Ron Joosten and Marc Kuijpers
Founders, Intergrin
Contacter l'équipe de la transaction
Casper Oude Essink
Oaklins Netherlands
Niels Vermuë
Oaklins Netherlands
Transactions connexes
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
En apprendre plusSurcos has completed a liability managament process
The shareholders of Surcos have completed a liability management process, which includes the issuance of US$5 million and a debt exchange totaling US$20 million.
En apprendre plusVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
En apprendre plus